|
| Study | Population | Results |
|
|
Olesen et al., 2005 [28] | 21 type 1/type 2 patients | Increased OPG levels in the aortic tunica media are associated with vascular calcifications |
|
Browner et al., 2001 [37] | 35 type 2 patients | OPG is associated with cardiovascular mortality |
|
Avignon et al., 2007 [51] | 465 type 1/type 2 patients | OPG is associated with silent myocardial ischemia |
|
Rasmussen et al., 2006 [52] | 400 type 1 patients | OPG is associated with poor glycemic control and CVD |
|
Blazquez-Medela et al., 2012 [53] | 52 type 2 patients | OPG is an indicator of endothelial dysfunction and CVD risk |
|
Altinova et al., 2011 [57] | 166 type 2 patients | OPG is associated with poor glycemic control and microalbuminuria |
|
Grauslund et al., 2010 [58] | 200 type 1 patients | OPG is associated with nephropathy |
|
Poulsen et al., 2011 [61] | 735 type 2 patients | OPG is associated with carotid and peripheral arterial disease |
|
Ishiyama et al., 2009 [62] | 168 type 2 patients | OPG is positively associated with vascular calcifications and CIMT |
|
Shin et al., 2006 [63] | 104 type 2 patients | OPG levels are associated with endothelial dysfunction |
|
Terekeci et al., 2009 [64] | 42 type 2 patients | OPG levels are associated with neuropathy |
|
Xiang et al., 2007 [70] | 22 type 1 patients | OPG are associated with endothelial function |
|